Michael R. Boyd

Active 1974–2024

116
Papers
26,148
Citations
90
h-index
116
i10-index

Citations

Citations per year for Michael R. Boyd1976: 1 citations1977: 6 citations1978: 3 citations1979: 11 citations1980: 19 citations1981: 4 citations1982: 9 citations1983: 7 citations1984: 18 citations1985: 5 citations1986: 12 citations1987: 7 citations1988: 12 citations1989: 24 citations1990: 33 citations1991: 40 citations1992: 41 citations1993: 63 citations1994: 57 citations1995: 69 citations1996: 87 citations1997: 113 citations1998: 119 citations1999: 148 citations2000: 175 citations2001: 222 citations2002: 206 citations2003: 256 citations2004: 285 citations2005: 270 citations2006: 238 citations2007: 206 citations2008: 197 citations2009: 187 citations2010: 209 citations2011: 190 citations2012: 157 citations2013: 127 citations2014: 124 citations2015: 115 citations2016: 97 citations2017: 107 citations2018: 84 citations2019: 385 citations2020: 422 citations2021: 337 citations2022: 241 citations2023: 158 citations2024: 241 citations2025: 97 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,696 citing papers, 27.2% of this breakdownChina: 394 citing papers, 6.3% of this breakdownUnited Kingdom: 308 citing papers, 4.9% of this breakdownGermany: 300 citing papers, 4.8% of this breakdownIndia: 286 citing papers, 4.6% of this breakdownEgypt: 232 citing papers, 3.7% of this breakdownJapan: 213 citing papers, 3.4% of this breakdownItaly: 206 citing papers, 3.3% of this breakdownAustralia: 160 citing papers, 2.6% of this breakdownFrance: 156 citing papers, 2.5% of this breakdownCanada: 140 citing papers, 2.2% of this breakdownSaudi Arabia: 131 citing papers, 2.1% of this breakdown
0%27.2%Other 32.4%

Fields

  • Biochemistry, Genetics and Molecular Biology33.1%
  • Medicine26.5%
  • Chemistry11.5%
  • Immunology and Microbiology6.7%
  • Agricultural and Biological Sciences6%
  • Pharmacology, Toxicology and Pharmaceutics5%
  • Other11.2%

Topics

  • Synthesis and biological activity2.8%
  • Microbial Natural Products and Biosynthesis2.6%
  • HIV Research and Treatment2.4%
  • Marine Sponges and Natural Products2.3%
  • Computational Drug Discovery Methods2.3%
  • HIV/AIDS drug development and treatment1.9%
  • Other85.7%

Coauthors

All papers

Open in search
  1. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

    Authors: , , , , , , , , , - 1988 cited by 3,104

  2. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

    Authors: , - Drug Development Research 1995 cited by 1,553

  3. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

    Authors: , , , , , , , , - 1988 cited by 2,365

  4. Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 2004 cited by 448

  5. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

    Authors: , , , , , - 1991 cited by 748

  6. Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

    Authors: , , , , , , , , , - Journal of the American Chemical Society 1994 cited by 306

  7. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

    Authors: , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 1997 cited by 614

  8. Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

    Authors: , , , , , , , - JNCI Journal of the National Cancer Institute 1989 cited by 969

  9. HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

    Authors: , , , , , , , , , - Journal of Medicinal Chemistry 1992 cited by 547

  10. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART

    Authors: , , , , , , - Blood 2001 cited by 328

  11. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?

    Authors: , , , , , , , , , - Journal of Clinical Pharmacy and Therapeutics 2016 cited by 133

  12. Cycloviolins A−D, Anti-HIV Macrocyclic Peptides from Leonia cymosa1

    Authors: , , , , , , , - The Journal of Organic Chemistry 1999 cited by 133

  13. Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin

    Authors: , , , , , , , , - Antimicrobial Agents and Chemotherapy 2003 cited by 189

  14. Anticancer Specificity of Some Ellipticinium Salts against Human Brain Tumors in vitro

    Authors: , , , , , - Journal of Medicinal Chemistry 1994 cited by 125

  15. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity

    Authors: , , , , , , , , , - Drug Discovery Today 2020 cited by 64

  16. A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Greg Gorman, Upender Manne, Sejong Bae, Bassel F. El‐Rayes, Gary A. Piazza - Cancer Research 2024 cited by 22

  17. Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6

    Authors: , , , , , , - Journal of Medicinal Chemistry 1995 cited by 391

  18. Papuamides A−D, HIV-Inhibitory and Cytotoxic Depsipeptides from the Sponges Theonella mirabilis and Theonella swinhoei Collected in Papua New Guinea

    Authors: , , , , , , , , , , , , - Journal of the American Chemical Society 1999 cited by 209

  19. A Novel Anti-HIV Macrocyclic Peptide from Palicourea condensata

    Authors: , , , , , - Journal of Natural Products 2001 cited by 151

  20. Structural diversity of xylans in the cell walls of monocots

    Authors: , , , , , - Planta 2016 cited by 113

  21. Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity 1 1Edited by P. E. Wright

    Authors: , , , , , - Journal of Molecular Biology 1999 cited by 111

  22. Neamphamide A, a New HIV-Inhibitory Depsipeptide from the Papua New Guinea Marine Sponge Neamphius huxleyi

    Authors: , , , , , , , , - Journal of Natural Products 2004 cited by 136

  23. Cytochrome P4502E (CYP2E) in Brain: Constitutive Expression, Induction by Ethanol and Localization by Fluorescence in Situ Hybridization

    Authors: , , , , - Archives of Biochemistry and Biophysics 2000 cited by 131

  24. : Isolation and structure of halistatin 1 from the eastern Indian Ocean marine sponge Phakellia carteri

    Authors: , , , , , , , , - The Journal of Organic Chemistry 1993 cited by 112